Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Study of Patients to Evaluate NIMBUS Revascularization Effectiveness With Challenging Occlusions

NCT03898960 is registered in ClinicalTrials.gov with Neuravi Limited as lead sponsor.

NCT NCT03898960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03898960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Study of Patients to Evaluate NIMBUS Revascularization Effectiveness With Challenging Occlusions
Lead sponsor
Neuravi Limited
Phase
Observational
Overall status
Completed
Start date
October 30, 2019
Completion date
April 8, 2022
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral stroke